SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-23-001637
Filing Date
2023-02-14
Accepted
2023-02-14 06:33:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 EFFECTOR THERAPEUTICS, INC. p23-0619sc13ga.htm SC 13G/A 72947
  Complete submission text file 0000902664-23-001637.txt   74600
Mailing Address 10250 CONSTELLATION BOULEVARD SUITE 2950 LOS ANGELES CA 90067
Business Address 10250 CONSTELLATION BOULEVARD SUITE 2950 LOS ANGELES CA 90067 (310)843-9900
Empyrean Capital Partners, LP (Filed by) CIK: 0001317195 (see all company filings)

IRS No.: 522403815 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91982 | Film No.: 23622083
SIC: 2834 Pharmaceutical Preparations